Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis

Overview of attention for article published in Core Evidence, September 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 39 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 134 followers.

Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressi... http://t.co/ZfoSYZP5XB

Reply Repost Favourite

Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressi... http://t.co/Um9AVjKXhd

Reply Repost Favourite